arrow
E

Enrico Tiacci

Melbourne Health
H指数:45
被引数:9,880

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Updated consensus guidelines for the diagnosis and management of patients with hairy cell leukemia (HCL) and HCL variant

毛细胞白血病(HCL)和HCL变异型的诊断与管理更新共识指南

Blood
IF23.1
2026-04-160
PRE
Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R)

vemurafenib联合利妥昔单抗治疗复发或难治性毛细胞白血病的真实世界疗效与安全性:一项多中心意大利回顾性研究(HCL-PG03R)

2025-11-140
OAAI
An Uncommon Localization of Hairy Cell Leukemia: Central Nervous System Involvement and Response to Ibrutinib—A Case Report and a Review of the Literature

毛细胞白血病的不常见定位:中枢神经系统受累及伊布替尼的治疗反应——病例报告及文献综述

2025-10-310
OAAI
Common origin and somatic mutation patterns of composite lymphomas and leukemias

复合淋巴瘤和白血病的共同起源和体细胞突变模式

LEUKEMIA
IF13.4
2025-05-220
OA
Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms
LEUKEMIA
IF13.4
2024-06-084
OAAI
The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (vol 36, pg 1720, 2022)

世界卫生组织第5版血淋巴肿瘤分类: 淋巴肿瘤 (第36卷,1720页,2022)

LEUKEMIA
IF13.4
2023-07-1915
OAAI
B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma
2023-05-047
OAAI
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia
2022-12-1313
OAAI
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study
2022-07-1914
OAAI
Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation
2022-06-0812
OAAI